2,662
Views
45
CrossRef citations to date
0
Altmetric
Research Article

Anti-inflammatory activity of essential oils from Syzygium cumini and Psidium guajava

, , &
Pages 881-887 | Received 19 Jun 2012, Accepted 17 Jan 2013, Published online: 11 Apr 2013

Figures & data

Figure 1. Kugelrohr distillation apparatus. A – oven (350 W); B – sample flask; C – receipting flask; D – cooling bath (dry ice/acetone); E – rotary system/vacuum outlet/support.

Figure 1. Kugelrohr distillation apparatus. A – oven (350 W); B – sample flask; C – receipting flask; D – cooling bath (dry ice/acetone); E – rotary system/vacuum outlet/support.

Table 1. Constitution of the leaf essential oils and the more (+V) and less (−V) volatile fractions from S. cumini and P. guajava after the Kugelrhor distillation.

Figure 2. Relative contents of monoterpenes and sesquiterpenes in the original samples and the more (+V) and less (−V) volatile fractions from distillation of S. cumini (SC) and P. guajava (PG) essential oils. Identified compounds: M-Hc = monoterpenes hydrocarbons; M-Ox = oxydized monoterpenes; S-Hc = sesquiterpenes hydrocarbons; S-Ox = oxydized sesquiterpenes. Identified compounds: M-Hc = monoterpenes hydrocarbons; M-Ox = oxydized monoterpenes; S-Hc = sesquiterpenes hydrocarbons; S-Ox = oxydized sesquiterpenes.

Figure 2. Relative contents of monoterpenes and sesquiterpenes in the original samples and the more (+V) and less (−V) volatile fractions from distillation of S. cumini (SC) and P. guajava (PG) essential oils. Identified compounds: M-Hc = monoterpenes hydrocarbons; M-Ox = oxydized monoterpenes; S-Hc = sesquiterpenes hydrocarbons; S-Ox = oxydized sesquiterpenes. Identified compounds: M-Hc = monoterpenes hydrocarbons; M-Ox = oxydized monoterpenes; S-Hc = sesquiterpenes hydrocarbons; S-Ox = oxydized sesquiterpenes.

Figure 3. Effect of S. cumini (SC), more (+V) and less (−V) volatile fractions on LPS-induced total leukocyte, mononuclear cells, neutrophils and eosinophils recruitment. Oil (100 mg/kg; hatched columns) or vehicle (open and closed columns) was administered p.o. 1 h prior to LPS (250 ng/cavity) and pleural fluid was collected 24 h later. + and * indicate p < 0.05 when compared to control non-stimulated saline injected (open columns) or LPS-stimulated saline-treated group (closed columns), respectively.

Figure 3. Effect of S. cumini (SC), more (+V) and less (−V) volatile fractions on LPS-induced total leukocyte, mononuclear cells, neutrophils and eosinophils recruitment. Oil (100 mg/kg; hatched columns) or vehicle (open and closed columns) was administered p.o. 1 h prior to LPS (250 ng/cavity) and pleural fluid was collected 24 h later. + and * indicate p < 0.05 when compared to control non-stimulated saline injected (open columns) or LPS-stimulated saline-treated group (closed columns), respectively.

Figure 4. Effect of P. guajava (PG), more (+V) and less (−V) volatile fractions on LPS-induced total leukocyte, mononuclear cells, neutrophils and eosinophils recruitment. Oil (100 mg/kg; hatched columns) or vehicle (open and closed columns) was administered p.o. 1 h prior to LPS (250 ng/cavity) and pleural fluid was collected 24 h later. + and * indicate p < 0.05 when compared to control non-stimulated saline injected (open columns) or LPS-stimulated saline-treated group (closed columns), respectively. Oil (100 mg/kg; hatched columns) or vehicle (open and closed columns) was administered p.o. 1 h prior to LPS (250 ng/cavity) and pleural fluid was collected 24 h later. + and * indicate p < 0.05 when compared to control non-stimulated saline injected (open columns) or LPS-stimulated saline-treated group (closed columns), respectively.

Figure 4. Effect of P. guajava (PG), more (+V) and less (−V) volatile fractions on LPS-induced total leukocyte, mononuclear cells, neutrophils and eosinophils recruitment. Oil (100 mg/kg; hatched columns) or vehicle (open and closed columns) was administered p.o. 1 h prior to LPS (250 ng/cavity) and pleural fluid was collected 24 h later. + and * indicate p < 0.05 when compared to control non-stimulated saline injected (open columns) or LPS-stimulated saline-treated group (closed columns), respectively. Oil (100 mg/kg; hatched columns) or vehicle (open and closed columns) was administered p.o. 1 h prior to LPS (250 ng/cavity) and pleural fluid was collected 24 h later. + and * indicate p < 0.05 when compared to control non-stimulated saline injected (open columns) or LPS-stimulated saline-treated group (closed columns), respectively.

Figure 5. Effect of β-caryophyllene (β-Ca), β-caryophyllene oxide (OxCa), β-pinene (β-Pi) and α-pinene (α-Pi) on LPS-induced total leukocyte and eosinophils recruitment. Sample (100 mg/kg; hatched columns) or vehicle (open and closed columns) was administered p.o. 1 h prior to LPS (250 ng/cavity) and pleural fluid was collected 24 h later. * Indicates p < 0.05 when compared to control non-stimulated saline injected (open columns) or LPS-stimulated saline-treated group (closed columns), respectively. Dexametasona (DEXA, 2 mg/kg) was the positive control.

Figure 5. Effect of β-caryophyllene (β-Ca), β-caryophyllene oxide (OxCa), β-pinene (β-Pi) and α-pinene (α-Pi) on LPS-induced total leukocyte and eosinophils recruitment. Sample (100 mg/kg; hatched columns) or vehicle (open and closed columns) was administered p.o. 1 h prior to LPS (250 ng/cavity) and pleural fluid was collected 24 h later. * Indicates p < 0.05 when compared to control non-stimulated saline injected (open columns) or LPS-stimulated saline-treated group (closed columns), respectively. Dexametasona (DEXA, 2 mg/kg) was the positive control.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.